nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—FMO3—Dapsone—leprosy	0.392	0.452	CbGbCtD
Almotriptan—CYP2E1—Thalidomide—leprosy	0.0635	0.0731	CbGbCtD
Almotriptan—CYP2E1—Rifampicin—leprosy	0.0615	0.0708	CbGbCtD
Almotriptan—CYP2E1—Dapsone—leprosy	0.0507	0.0585	CbGbCtD
Almotriptan—CYP2C8—Rifampicin—leprosy	0.0459	0.0529	CbGbCtD
Almotriptan—CYP2C19—Thalidomide—leprosy	0.0398	0.0458	CbGbCtD
Almotriptan—CYP2C19—Rifampicin—leprosy	0.0385	0.0444	CbGbCtD
Almotriptan—CYP2C8—Dapsone—leprosy	0.0379	0.0437	CbGbCtD
Almotriptan—CYP1A2—Thalidomide—leprosy	0.0367	0.0423	CbGbCtD
Almotriptan—CYP1A2—Rifampicin—leprosy	0.0356	0.041	CbGbCtD
Almotriptan—CYP2C19—Dapsone—leprosy	0.0318	0.0366	CbGbCtD
Almotriptan—FMO3—sweat—leprosy	0.025	0.363	CbGeAlD
Almotriptan—CYP3A4—Rifampicin—leprosy	0.0186	0.0215	CbGbCtD
Almotriptan—CYP3A4—Dapsone—leprosy	0.0154	0.0177	CbGbCtD
Almotriptan—HTR1B—trigeminal nerve—leprosy	0.00787	0.114	CbGeAlD
Almotriptan—HTR1D—trigeminal nerve—leprosy	0.00762	0.111	CbGeAlD
Almotriptan—HTR1B—cranial nerve—leprosy	0.00561	0.0816	CbGeAlD
Almotriptan—HTR1D—cranial nerve—leprosy	0.00543	0.079	CbGeAlD
Almotriptan—HTR1B—blood vessel—leprosy	0.00226	0.0328	CbGeAlD
Almotriptan—HTR1D—blood vessel—leprosy	0.00219	0.0318	CbGeAlD
Almotriptan—MAOA—nerve—leprosy	0.00212	0.0308	CbGeAlD
Almotriptan—FMO3—eye—leprosy	0.00205	0.0298	CbGeAlD
Almotriptan—Nystagmus—Thalidomide—leprosy	0.00146	0.0231	CcSEcCtD
Almotriptan—Muscular weakness—Dapsone—leprosy	0.0013	0.0207	CcSEcCtD
Almotriptan—Myocardial ischaemia—Thalidomide—leprosy	0.0013	0.0206	CcSEcCtD
Almotriptan—Vasodilation procedure—Thalidomide—leprosy	0.00119	0.0188	CcSEcCtD
Almotriptan—Vasodilation—Thalidomide—leprosy	0.00119	0.0188	CcSEcCtD
Almotriptan—Photosensitivity reaction—Dapsone—leprosy	0.00117	0.0185	CcSEcCtD
Almotriptan—HTR1D—eye—leprosy	0.00116	0.0169	CbGeAlD
Almotriptan—Bone disorder—Thalidomide—leprosy	0.00116	0.0183	CcSEcCtD
Almotriptan—FMO3—testis—leprosy	0.00112	0.0163	CbGeAlD
Almotriptan—Neuropathy peripheral—Dapsone—leprosy	0.00112	0.0177	CcSEcCtD
Almotriptan—Hypercholesterolaemia—Thalidomide—leprosy	0.0011	0.0175	CcSEcCtD
Almotriptan—FMO3—nervous system—leprosy	0.0011	0.016	CbGeAlD
Almotriptan—Sinusitis—Dapsone—leprosy	0.00107	0.0169	CcSEcCtD
Almotriptan—Coordination abnormal—Thalidomide—leprosy	0.00106	0.0168	CcSEcCtD
Almotriptan—Neck pain—Thalidomide—leprosy	0.00106	0.0167	CcSEcCtD
Almotriptan—Pharyngitis—Dapsone—leprosy	0.00102	0.0161	CcSEcCtD
Almotriptan—Colitis—Thalidomide—leprosy	0.001	0.0159	CcSEcCtD
Almotriptan—Neuropathy—Thalidomide—leprosy	0.00098	0.0155	CcSEcCtD
Almotriptan—Dry eye—Thalidomide—leprosy	0.000964	0.0153	CcSEcCtD
Almotriptan—Tinnitus—Dapsone—leprosy	0.000954	0.0151	CcSEcCtD
Almotriptan—Hypertonia—Thalidomide—leprosy	0.000915	0.0145	CcSEcCtD
Almotriptan—Mental disability—Thalidomide—leprosy	0.000905	0.0143	CcSEcCtD
Almotriptan—Euphoric mood—Thalidomide—leprosy	0.000896	0.0142	CcSEcCtD
Almotriptan—Erythema—Dapsone—leprosy	0.000891	0.0141	CcSEcCtD
Almotriptan—Gastroenteritis—Thalidomide—leprosy	0.000855	0.0135	CcSEcCtD
Almotriptan—Vision blurred—Dapsone—leprosy	0.00084	0.0133	CcSEcCtD
Almotriptan—Eye pain—Thalidomide—leprosy	0.000839	0.0133	CcSEcCtD
Almotriptan—Vertigo—Dapsone—leprosy	0.0008	0.0127	CcSEcCtD
Almotriptan—Arthritis—Thalidomide—leprosy	0.000779	0.0123	CcSEcCtD
Almotriptan—Diplopia—Thalidomide—leprosy	0.000757	0.012	CcSEcCtD
Almotriptan—Pain in extremity—Thalidomide—leprosy	0.000757	0.012	CcSEcCtD
Almotriptan—Tachycardia—Dapsone—leprosy	0.00071	0.0112	CcSEcCtD
Almotriptan—Breast disorder—Thalidomide—leprosy	0.000684	0.0108	CcSEcCtD
Almotriptan—Muscular weakness—Thalidomide—leprosy	0.000668	0.0106	CcSEcCtD
Almotriptan—Insomnia—Dapsone—leprosy	0.000658	0.0104	CcSEcCtD
Almotriptan—HTR1B—nervous system—leprosy	0.000647	0.0094	CbGeAlD
Almotriptan—Angina pectoris—Thalidomide—leprosy	0.000638	0.0101	CcSEcCtD
Almotriptan—Bronchitis—Thalidomide—leprosy	0.00063	0.00997	CcSEcCtD
Almotriptan—HTR1D—nervous system—leprosy	0.000626	0.0091	CbGeAlD
Almotriptan—Photosensitivity reaction—Thalidomide—leprosy	0.000597	0.00946	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dapsone—leprosy	0.000595	0.00942	CcSEcCtD
Almotriptan—Hyperglycaemia—Thalidomide—leprosy	0.00059	0.00935	CcSEcCtD
Almotriptan—MAOA—tendon—leprosy	0.000587	0.00853	CbGeAlD
Almotriptan—Acute coronary syndrome—Thalidomide—leprosy	0.000575	0.00911	CcSEcCtD
Almotriptan—Abdominal pain—Dapsone—leprosy	0.000575	0.0091	CcSEcCtD
Almotriptan—Body temperature increased—Dapsone—leprosy	0.000575	0.0091	CcSEcCtD
Almotriptan—Neuropathy peripheral—Thalidomide—leprosy	0.000572	0.00906	CcSEcCtD
Almotriptan—Myocardial infarction—Thalidomide—leprosy	0.000572	0.00906	CcSEcCtD
Almotriptan—Conjunctivitis—Thalidomide—leprosy	0.000567	0.00898	CcSEcCtD
Almotriptan—Epistaxis—Thalidomide—leprosy	0.000551	0.00872	CcSEcCtD
Almotriptan—Sinusitis—Thalidomide—leprosy	0.000548	0.00867	CcSEcCtD
Almotriptan—Rhinitis—Thalidomide—leprosy	0.000525	0.00832	CcSEcCtD
Almotriptan—Hypoaesthesia—Thalidomide—leprosy	0.000521	0.00826	CcSEcCtD
Almotriptan—Pharyngitis—Thalidomide—leprosy	0.00052	0.00824	CcSEcCtD
Almotriptan—Visual impairment—Thalidomide—leprosy	0.000505	0.008	CcSEcCtD
Almotriptan—Eye disorder—Thalidomide—leprosy	0.00049	0.00775	CcSEcCtD
Almotriptan—Tinnitus—Thalidomide—leprosy	0.000489	0.00774	CcSEcCtD
Almotriptan—Cardiac disorder—Thalidomide—leprosy	0.000486	0.0077	CcSEcCtD
Almotriptan—MAOA—testis—leprosy	0.000486	0.00706	CbGeAlD
Almotriptan—MAOA—nervous system—leprosy	0.000477	0.00693	CbGeAlD
Almotriptan—Immune system disorder—Thalidomide—leprosy	0.000473	0.00749	CcSEcCtD
Almotriptan—Chills—Thalidomide—leprosy	0.00047	0.00745	CcSEcCtD
Almotriptan—Vomiting—Dapsone—leprosy	0.000462	0.00732	CcSEcCtD
Almotriptan—Mental disorder—Thalidomide—leprosy	0.000459	0.00727	CcSEcCtD
Almotriptan—Headache—Dapsone—leprosy	0.000456	0.00721	CcSEcCtD
Almotriptan—Tension—Thalidomide—leprosy	0.000448	0.00709	CcSEcCtD
Almotriptan—Dysgeusia—Thalidomide—leprosy	0.000447	0.00707	CcSEcCtD
Almotriptan—Nervousness—Thalidomide—leprosy	0.000443	0.00702	CcSEcCtD
Almotriptan—Back pain—Thalidomide—leprosy	0.000441	0.00699	CcSEcCtD
Almotriptan—CYP2E1—tendon—leprosy	0.00044	0.0064	CbGeAlD
Almotriptan—CYP2C8—testis—leprosy	0.000433	0.0063	CbGeAlD
Almotriptan—Nausea—Dapsone—leprosy	0.000432	0.00684	CcSEcCtD
Almotriptan—Vision blurred—Thalidomide—leprosy	0.00043	0.00681	CcSEcCtD
Almotriptan—Tremor—Thalidomide—leprosy	0.000427	0.00677	CcSEcCtD
Almotriptan—Ill-defined disorder—Thalidomide—leprosy	0.000423	0.0067	CcSEcCtD
Almotriptan—Agitation—Thalidomide—leprosy	0.000419	0.00664	CcSEcCtD
Almotriptan—Angioedema—Thalidomide—leprosy	0.000417	0.0066	CcSEcCtD
Almotriptan—Malaise—Thalidomide—leprosy	0.000411	0.00651	CcSEcCtD
Almotriptan—Vertigo—Thalidomide—leprosy	0.00041	0.00649	CcSEcCtD
Almotriptan—Syncope—Thalidomide—leprosy	0.000409	0.00648	CcSEcCtD
Almotriptan—Palpitations—Thalidomide—leprosy	0.000403	0.00638	CcSEcCtD
Almotriptan—Loss of consciousness—Thalidomide—leprosy	0.000401	0.00635	CcSEcCtD
Almotriptan—Convulsion—Thalidomide—leprosy	0.000395	0.00626	CcSEcCtD
Almotriptan—Hypertension—Thalidomide—leprosy	0.000394	0.00624	CcSEcCtD
Almotriptan—Arthralgia—Thalidomide—leprosy	0.000388	0.00615	CcSEcCtD
Almotriptan—Chest pain—Thalidomide—leprosy	0.000388	0.00615	CcSEcCtD
Almotriptan—Myalgia—Thalidomide—leprosy	0.000388	0.00615	CcSEcCtD
Almotriptan—Anxiety—Thalidomide—leprosy	0.000387	0.00613	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000386	0.00611	CcSEcCtD
Almotriptan—Discomfort—Thalidomide—leprosy	0.000384	0.00608	CcSEcCtD
Almotriptan—Dry mouth—Thalidomide—leprosy	0.00038	0.00601	CcSEcCtD
Almotriptan—Confusional state—Thalidomide—leprosy	0.000375	0.00594	CcSEcCtD
Almotriptan—Shock—Thalidomide—leprosy	0.000366	0.0058	CcSEcCtD
Almotriptan—Nervous system disorder—Thalidomide—leprosy	0.000365	0.00578	CcSEcCtD
Almotriptan—CYP2E1—testis—leprosy	0.000365	0.0053	CbGeAlD
Almotriptan—Tachycardia—Thalidomide—leprosy	0.000363	0.00575	CcSEcCtD
Almotriptan—Skin disorder—Thalidomide—leprosy	0.000362	0.00573	CcSEcCtD
Almotriptan—Hyperhidrosis—Thalidomide—leprosy	0.00036	0.0057	CcSEcCtD
Almotriptan—CYP2E1—nervous system—leprosy	0.000358	0.0052	CbGeAlD
Almotriptan—Musculoskeletal discomfort—Thalidomide—leprosy	0.000339	0.00537	CcSEcCtD
Almotriptan—Insomnia—Thalidomide—leprosy	0.000337	0.00533	CcSEcCtD
Almotriptan—Paraesthesia—Thalidomide—leprosy	0.000334	0.00529	CcSEcCtD
Almotriptan—Dyspnoea—Thalidomide—leprosy	0.000332	0.00526	CcSEcCtD
Almotriptan—Somnolence—Thalidomide—leprosy	0.000331	0.00524	CcSEcCtD
Almotriptan—Dyspepsia—Thalidomide—leprosy	0.000328	0.00519	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Thalidomide—leprosy	0.000321	0.00509	CcSEcCtD
Almotriptan—Fatigue—Thalidomide—leprosy	0.000321	0.00508	CcSEcCtD
Almotriptan—Pain—Thalidomide—leprosy	0.000318	0.00504	CcSEcCtD
Almotriptan—Feeling abnormal—Thalidomide—leprosy	0.000307	0.00486	CcSEcCtD
Almotriptan—Gastrointestinal pain—Thalidomide—leprosy	0.000304	0.00482	CcSEcCtD
Almotriptan—Abdominal pain—Thalidomide—leprosy	0.000294	0.00466	CcSEcCtD
Almotriptan—Body temperature increased—Thalidomide—leprosy	0.000294	0.00466	CcSEcCtD
Almotriptan—CYP2D6—testis—leprosy	0.000289	0.0042	CbGeAlD
Almotriptan—CYP3A4—nervous system—leprosy	0.000288	0.00419	CbGeAlD
Almotriptan—CYP2D6—nervous system—leprosy	0.000283	0.00412	CbGeAlD
Almotriptan—Hypersensitivity—Thalidomide—leprosy	0.000274	0.00434	CcSEcCtD
Almotriptan—Asthenia—Thalidomide—leprosy	0.000267	0.00423	CcSEcCtD
Almotriptan—Pruritus—Thalidomide—leprosy	0.000263	0.00417	CcSEcCtD
Almotriptan—Diarrhoea—Thalidomide—leprosy	0.000255	0.00403	CcSEcCtD
Almotriptan—Dizziness—Thalidomide—leprosy	0.000246	0.0039	CcSEcCtD
Almotriptan—Vomiting—Thalidomide—leprosy	0.000237	0.00375	CcSEcCtD
Almotriptan—Rash—Thalidomide—leprosy	0.000235	0.00372	CcSEcCtD
Almotriptan—Dermatitis—Thalidomide—leprosy	0.000234	0.00371	CcSEcCtD
Almotriptan—Headache—Thalidomide—leprosy	0.000233	0.00369	CcSEcCtD
Almotriptan—Nausea—Thalidomide—leprosy	0.000221	0.0035	CcSEcCtD
